NFG
CSTL icon

Next Financial Group’s Castle Biosciences CSTL Stock Holding History

Next Financial Group’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$24K Sell
557
-2,595
-82% -$136K ﹤0.01% 1803
2021
Q3 		$210K Buy
3,152
+715
+29% +$50.3K 0.02% 813
2021
Q2 		$179K Buy
2,437
+2,428
+26,978% +$160K 0.01% 866
2021
Q1 		$1K Buy
+9
New +$676 ﹤0.01% 2390

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Next Financial Group's CSTL Position: Q4 2021 in Review

Next Financial Group reduced its Castle Biosciences (CSTL) stake by 82% in Q4 2021, selling an estimated $136K and leaving 557 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Next Financial Group first reported a position in CSTL in Q1 2021 and has held it in 4 quarters since. The position peaked at $210K in Q3 2021. 159 funds tracked by Wall St. Rank hold CSTL as of Q4 2021.

  • Next Financial Group held 557 shares of Castle Biosciences worth $24K as of Q4 2021.
  • Next Financial Group sold 2,595 Castle Biosciences shares in Q4 2021, an estimated $136K.
  • Castle Biosciences made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1803 holding.
  • Next Financial Group first reported a position in Castle Biosciences in Q1 2021 and has held it in 4 quarters since.
  • Next Financial Group's Castle Biosciences position peaked at $210K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.